Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...
Researchers from Australia have developed a groundbreaking mRNA vaccine against tuberculosis (TB), showing promising results in pre-clinical mouse trials. This innovative vaccine could outperform the ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful ...
Wassiti, Monash Institute of Pharmaceutical SciencesA novel vaccine that boosts immunity against tuberculosis (TB) has been shown to be ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
GlobalData on MSN1d
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancerImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
Hosted on MSN1d
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail Buzz IntensifiesShares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...
ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an "alternative source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback